• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Impilo Secures $11.5M to Expand Access to At-Home Healthcare

by Fred Pennic 11/14/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Impilo, a digital health platform revolutionizing healthcare access raises $11.5M in a Series A funding round led by Construct Capital, with participation from GC 1 Capital, One Way Ventures, 2048 Ventures, and strategic angel investors.

– Impilo’s vision is a world where access to world-class healthcare is no longer limited by location or circumstance. By leveraging technology and innovation, Impilo is making this vision a reality, bringing convenient, high-quality care to patients wherever they are.

Revolutionizing Healthcare Access for At-Home Care

Founded in 2020, Impilo is committed to eliminating barriers to receiving healthcare at home. By combining cutting-edge technology with a patient-centric approach, Impilo empowers healthcare providers to deliver high-quality care directly to patients’ homes.

Impilo’s platform offers a comprehensive suite of solutions for at-home care delivery:

  • 4PL Logistics: Streamlines the delivery of medical supplies, equipment, and diagnostics to patients’ homes.
  • Patient Support: Provides seamless and personalized support to patients throughout their at-home care journey.
  • Data Connectivity: Enables secure and efficient data exchange between patients, providers, and connected devices.
  • Integrated Ecosystem: Connects a network of devices, diagnostics, and medical supplies to create a comprehensive at-home care experience.
  • White-Labeled Solution: Allows healthcare providers to offer Impilo’s platform under their own brand, ensuring a consistent patient experience.

Fueling Expansion and Innovation

The Series A funding will enable Impilo to:

  • Enhance Technology Infrastructure: Invest in further development and refinement of its platform.
  • Expand Geographic Reach: Scale its operations to new regions, increasing access to at-home care for more patients.
  • Improve User Experience: Refine the platform’s user interface and functionality to enhance patient and provider satisfaction.
  • Launch New Offerings: Expand its portfolio of at-home care services and solutions.

“This funding is a game-changer for us,” said Josh Stein, CEO of Impilo. “It will allow us to supercharge our growth, expand our footprint across the provider and payer sectors, and continue to innovate on a platform that makes high-quality healthcare more accessible than ever. We are deeply grateful to our investors and team members who share our vision for a future where healthcare is no longer confined to physical locations, but is available anytime, anywhere.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: home health

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |